Yang Relin, Cheung Michael C, Franceschi Dido, Hurley Judith, Huang Youjie, Livingstone Alan S, Koniaris Leonidas G
DeWitt Daughtry Family Department of Surgery, University of Miami, Miller School of Medicine, Miami, FL 33136, USA.
J Am Coll Surg. 2009 May;208(5):853-68; discussion 869-70. doi: 10.1016/j.jamcollsurg.2008.10.038. Epub 2009 Jan 21.
Determine the effect of race, socioeconomic status (SES) and other demographic variables on outcomes of patients with invasive ductal and lobular breast cancer.
Florida cancer registry and inpatient hospital data were queried for patients diagnosed with invasive breast cancer from 1998 to 2002.
A total of 63,472 patients with breast cancer were identified. Overall, 90.5% of patients were Caucasian, 7.6% African American, and 8.7% Hispanic. African-American patients presented at a younger age and with more-advanced disease, 10.5% presented with breast cancer before the age of 40 years, and 22.4% before 45 years of age. African-American patients were less likely to undergo operations. Similarly, low-SES patients were less likely to have operations and presented more often with larger tumors. Stepwise multivariate analysis revealed a substantial drop in the hazard ratio for African-American patients once correction for stage of presentation was made, suggesting that disparities in breast cancer outcomes are, in part, a result of advanced stage at presentation. Race and low SES were independent predictors of worse prognosis when controlling for patient comorbidities and treatment.
Dramatic disparities by patient race and SES exist in breast cancer. Our study integrates previous smaller studies, providing comprehensive insight into African-American patients and their outcomes for breast cancer. Earlier screening programs and greater access to cancer care for the poor and African Americans are needed. Successful institution of such programs will not completely erase disparities in outcomes for breast cancer in African-American patients.
确定种族、社会经济地位(SES)及其他人口统计学变量对浸润性导管癌和小叶癌患者预后的影响。
查询了佛罗里达癌症登记处和住院医院数据,以获取1998年至2002年被诊断为浸润性乳腺癌的患者信息。
共识别出63472例乳腺癌患者。总体而言,90.5%的患者为白人,7.6%为非裔美国人,8.7%为西班牙裔。非裔美国患者就诊时年龄较轻且疾病分期更晚,10.5%的患者在40岁之前被诊断为乳腺癌,22.4%在45岁之前。非裔美国患者接受手术的可能性较小。同样,低SES患者接受手术的可能性较小,且更常出现较大肿瘤。逐步多变量分析显示,一旦对就诊分期进行校正,非裔美国患者的风险比大幅下降,这表明乳腺癌预后的差异部分是由于就诊时分期较晚所致。在控制患者合并症和治疗情况时,种族和低SES是预后较差的独立预测因素。
乳腺癌患者的种族和SES存在显著差异。我们的研究整合了之前较小规模的研究,为非裔美国患者及其乳腺癌预后提供了全面的见解。需要为贫困人群和非裔美国人开展更早的筛查项目,并提供更多获得癌症治疗的机会。成功实施此类项目不会完全消除非裔美国患者乳腺癌预后的差异。